Trial Condition(s):
Long-term study in Chronic Kidney Disease (Extension from Study 14817)
15074
Not Available
Not Available
The objective of this study is to investigate the safety and the effect on reduction of serum phosphate of long-term administration of lanthanum carbonate (BAY77-1931) 750 to 2250 mg in patients with hyperphosphatemia who completed the 8 week double-blind treatment period of Study 14817 and are judged to be eligible for the long-term extension study.
- Patients who have completed the 8-week double-blind treatment period of Study 14817 and are judged to be eligible for the long-term extension study by the investigator (including those who plan to be on dialysis during the long-term extension study).
- Patients with any other conditions that the investigator defines as not appropriate to be enrolled in the study
Locations | |
---|---|
Locations Wakayama Medical University Hospital Wakayama, Japan, 641-8510 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Osaka General Medical Center Osaka, Japan, 558-8558 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Osaka Rosai Hospital Sakai, Japan, 591-8025 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Osaka Saiseikai Nakatsu Hospital Osaka, Japan, 530-0012 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Kitano Hospital Osaka, Japan, 530-8480 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Okayama Saiseikai General Hospital Okayama, Japan, 700-0013 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Kurashiki Central Hospital Kurashiki, Japan, 710-8602 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations The Jikei University Hospital Minato-ku, Japan, 105-8471 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Chubu Rosai Hospital Nagoya, Japan, 455-8530 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Juntendo Tokyo Koto Geriatric Medical Center Koto, Japan, 136-0075 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Fujisawa City Hospital Fujisawa, Japan, 251-8550 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Narita Memorial Hospital Toyohashi, Japan, 441-8021 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Kawashima Hospital Tokushima, Japan, 770-0011 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Osaka City General Hospital Osaka, Japan, 534-0021 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations NTT Medical Center Tokyo Shinagawa, Japan, 141-8625 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Musashino Red Cross Hospital Musashino, Japan, 180-8610 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Shonan Kamakura General Hospital Kamakura, Japan, 247-8533 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Kameda Clinic Kamogawa, Japan, 296-0041 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Kainan Hospital Yatomi, Japan, 498-8502 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Nagoya Daini Red Cross Hospital Nagoya, Japan, 466-8650 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Kyushu Medical Center Fukuoka, Japan, 810-8563 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Kyoto Medical Center Kyoto, Japan, 612-8555 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Beppu Medical Center Beppu, Japan, 874-0011 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Oita Medical Center Oita, Japan, 870-0263 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Nagoya Medical Center Nagoya, Japan, 460-0001 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Tokyo Medical Center Meguro-ku, Japan, 152-8902 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Shizuoka Tokushukai Hospital Shizuoka, Japan, 421-0193 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Social Insurance Chukyo Hospital Nagoya, Japan, 457-8510 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Tosei General Hospital Seto, Japan, 489-8642 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Fukuoka University Hospital Fukuoka, Japan, 814-0180 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Saga Prefectural Hospital Koseikan Saga, Japan, 840-0054 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Hokkaido Medical Center Sapporo, Japan, 063-0005 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Kimitsu Chuo Hospital Kisarazu, Japan, 292-8535 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Kokura Memorial Hospital Kitakyushu, Japan, 802-0001 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations National Fukuoka-Higashi Medical Center Koga, Japan, 811-3195 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Hyogo Prefectural Amagasaki Hospital Amagasaki, Japan, 660-0828 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Saiseikai Yokohamashi Nanbu Hospital Yokohama, Japan, 234-8503 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Saiseikai Yahata General Hospital Kitakyushu, Japan, 805-0050 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Yokohama City Minato Red Cross Hospital Yokohama, Japan, 231-8682 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Anjo Kosei Hospital Anjo, Japan, 446-8602 | Contact Us: E-mail: [email protected] Phone: Not Available |
An open-label, long-term extension study of Lanthanum Carbonate 750 to 2,250 mg in hyperphosphatemia in patients with chronic kidney disease not on dialysis (52 weeks extension from Study 14817)
Trial Type:
Interventional
Intervention Type:
Drug
Trial Purpose:
Treatment
Allocation:
N/A
Blinding:
Open Label
Assignment:
Single Group Assignment
Trial Arms:
1